Successful Dabrafenib Desensitization Protocols in a Patient with Metastatic Melanoma

Successful Dabrafenib Desensitization Protocols in a Patient with Metastatic Melanoma

Dabrafenib and trametinib are two available molecules that have been approved for the treatment of metastatic melanoma with BRAF-V600E or V600K mutations. Their combined therapy has led to long-lasting survival benefits and substantially improved outcomes. Until now, only a few cases of severe hyper...

Full description

Bibliographic Details
Main Authors: Roxana Silvia Bumbacea, Selda Ali, Sabina Loredana Corcea, Dan Corneliu Jinga, Luiza Spiru
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Medicina
Subjects:
dabrafenib hypersensitivity
dabrafenib desensitization
metastatic melanoma
personalized treatment
Online Access:https://www.mdpi.com/1648-9144/58/4/511

Internet

https://www.mdpi.com/1648-9144/58/4/511

Similar Items